Health Care & Life Sciences » Healthcare Provision | Austar Lifesciences Ltd.

Austar Lifesciences Ltd. | Balance Sheet

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
217
483
495
370
381
335
Total Accounts Receivable
334
381
390
379
390
470
Inventories
95
86
89
101
93
150
Other Current Assets
49
51
63
42
42
63
Total Current Assets
695
1,002
1,037
892
906
1,018
Net Property, Plant & Equipment
42
48
52
47
50
58
Total Investments and Advances
25
23
22
39
48
54
Long-Term Note Receivable
-
-
-
10
10
11
Intangible Assets
2
2
3
5
8
10
Other Assets
8
8
27
25
26
62
Total Assets
776
1,087
1,147
1,021
1,058
1,222
ST Debt & Current Portion LT Debt
26
44
77
51
57
Accounts Payable
156
145
189
187
164
Income Tax Payable
17
10
4
1
1
Other Current Liabilities
388
182
200
155
248
Total Current Liabilities
587
381
469
394
470
Deferred Taxes
13
15
13
13
1
Total Liabilities
603
400
489
411
481
Common Equity (Total)
173
686
658
609
574
Total Shareholders' Equity
173
686
658
609
574
Total Equity
173
686
658
609
577
Liabilities & Shareholders' Equity
776
1,087
1,147
1,021
1,058
Accumulated Minority Interest
-
-
-
-
2
Non-Equity Reserves
-
-
-
1
1

About Austar Lifesciences

View Profile
Address
Room 1801, Building B
Beijing Beijing
China
Employees -
Website http://www.austar.com.hk
Updated 07/08/2019
Austar Lifesciences Ltd. is an investment holding company, which engages in the provision of engineering solutions to pharmaceutical manufacturers and research institutes. It operates through the following segments: Liquid and Bioprocess System; Clean Room and Automation Control and Monitoring System; Powder and Solid System; Good Manufacturing Practice (GMP) Compliance Service; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment. The Liquid and Bioprocess System segment provides solutions in pharmaceutical and water systems to treat water.